Interview with Teresa Maldonado Marchok: We’ve all heard about the dangers of osteoporosis — but did you know you should be ...
Rachel Smith told Newsweek that the back pain left her “unable to walk," but she never could have guessed what scans would ...
Getting the most out of A/B and other controlled tests by Ron Kohavi and Stefan Thomke In 2012 a Microsoft employee working on Bing had an idea about changing the way the search engine displayed ad ...
(NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Pfizer Inc. (NYSE: PFE) today announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating LORBRENA ® (lorlatinib, a third-generation ALK inhibitor, available in Europe ...
Rare cardiovascular diseases affect 5% of the world’s population. Rare disease training for clinicians is essential to suspect and diagnose underlying rare diseases and to work effectively with ...
With more than seven million daily users on the HotCopper forums, each and every discussion can move markets. That’s why ...